Tuesday - June 16, 2026

Category Archives: Science

Graves’ Disease Market is Projected to Witness Significant Growth by 2036 Owing to the Emergence of Novel Targeted Therapies and Expanding Treatment Landscape | DelveInsight

The Graves’ Disease market is expected to experience substantial growth through 2036, driven by the increasing diagnosed patient population, growing awareness of autoimmune thyroid disorders, rising diagnosis rates, and the launch of innovative targeted therapies. The emergence of promising therapies … Continue reading →

TSLP Inhibitors Market is Expected to Grow Significantly by 2036 Owing to Expanding Therapeutic Applications and Emerging Pipeline Therapies | DelveInsight

The TSLP Inhibitors market is anticipated to witness robust growth through 2036, driven by the increasing burden of inflammatory airway diseases, expanding therapeutic applications across asthma, chronic obstructive pulmonary disease (COPD), chronic rhinosinusitis with nasal polyps (CRSwNP), atopic dermatitis, and … Continue reading →

CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma Market Expected to Witness Significant Expansion Through 2034, According to DelveInsight

DelveInsight’s “CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma Market Insights, Epidemiology, and Market Forecast–2034” report delivers a comprehensive understanding of CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma, including historical and forecasted epidemiology trends as well as market dynamics across the United States, … Continue reading →

Diabetic Peripheral Neuropathy Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Diabetic Peripheral Neuropathy Pipeline Insight 2026” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Diabetic Peripheral Neuropathy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Spinal Cord Injury Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Spinal Cord Injury Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Spinal Cord Injury pipeline landscape. It covers the Spinal Cord Injury pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Fabry Disease Pipeline Shows Potential with Active Contributions from 18+ Key Companies | DelveInsight

DelveInsight’s “Fabry Disease Pipeline Insight 2026” report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in the Fabry Disease pipeline landscape. It covers the Fabry Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Polycythemia Vera Pipeline Expands as 20+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Polycythemia Vera Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Polycythemia Vera pipeline landscape. It covers the Polycythemia Vera pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Atopic Keratoconjunctivitis Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Atopic Keratoconjuctivitis Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Atopic Keratoconjuctivitis pipeline landscape. It covers the Atopic Keratoconjunctivitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Actinic Keratosis Therapeutics Market Size in the 7MM is projected to grow at a significant CAGR by 2036, estimates DelveInsight

DelveInsight’s “Actinic Keratosis Market Insights, Epidemiology, and Market Forecast- 2036′′ report offers an in-depth understanding of the Actinic Keratosis, historical and forecasted epidemiology as well as the Actinic Keratosis market trends in the United States, EU4 (Germany, Spain, Italy, France, … Continue reading →

Acute Kidney Injury Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Acute Kidney Injury Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Acute Kidney Injury pipeline landscape. It covers the Acute Kidney Injury Pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →